Minerva urology and nephrology · 2026
Minimally-invasive partial versus total adrenalectomy for unilateral aldosterone-producing adenomas and pheochromocytoma: long-term results from a multicenter Italian study applying the clinical cure system.
СтатьяМногоцентровое исследованиеСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Anceschi Umberto, Amparore Daniele, Basile Salvatore, Flammia Rocco S, Prata Francesco, Alemanno Giovanni, Buonanno Davide, Mormando Marilda, Zappalà Orazio, DE Concilio Bernardino, Carrara Alessandro, Quarà Alberto, Ortenzi Michele, Minore Antonio, Vescovo Mariavittoria, DE Cillis Sabrina T, Ragusa Alberto, Iannuzzi Andrea, Mastroianni Riccardo, Proietti Flavia, Appetecchia Marialuisa, Papalia Rocco, Leonardo Costantino, Fiori Cristian, Porpiglia Francesco, Celia Antonio, Prosperi Paolo, Simone Giuseppe
Аннотация
BACKGROUND: The aim of this study is to compare the long-term clinical outcomes of minimally invasive partial adrenalectomy (MIPA) and minimally invasive total adrenalectomy (MITA) in patients with benign functional adrenal disease, using a standardized clinical outcome metric.
METHODS: We conducted a retrospective, multicenter cohort study across six Italian institutions involved in the surgical management of adrenal disease. A total of 212 patients underwent MIPA (N.=41) or MITA (N.=171) for primary aldosteronism (PA, N.=111) or pheochromocytoma (PC, N.=101) between 2010 and 2022. Clinical outcomes were evaluated using the clinical cure classification proposed by Vorselaars et al., stratified by surgical approach and adrenal pathology. Perioperative parameters and postoperative steroidal replacement were also assessed.
RESULTS: Median follow-up was 53.9 months (IQR 31.4-103.1). Rates of clinical cure, clear improvement, and failure were 61.0%, 17.1%, and 21.9% in the MIPA group, and 70.1%, 15.3%, and 14.6% in the MITA group, respectively (all P>0.54). Postoperative steroidal replacement was more common after MITA (19.5% vs. 9.9%, P=0.80). When stratified by pathology, clinical cure was significantly more frequent in PC compared to PA (86.1% vs. 52.3%, P<0.001). Complication rates were low and comparable between groups (P=0.82).
CONCLUSIONS: In selected cases, MIPA offers long-term clinical outcomes comparable to MITA, with a lower trend in steroidal replacement. Stratification by pathology confirmed the greater clinical reversibility of PC compared to PA. The clinical cure system proved applicable across disease types and surgical strategies, supporting its broader use as a pragmatic evaluative tool in adrenal surgery.
METHODS: We conducted a retrospective, multicenter cohort study across six Italian institutions involved in the surgical management of adrenal disease. A total of 212 patients underwent MIPA (N.=41) or MITA (N.=171) for primary aldosteronism (PA, N.=111) or pheochromocytoma (PC, N.=101) between 2010 and 2022. Clinical outcomes were evaluated using the clinical cure classification proposed by Vorselaars et al., stratified by surgical approach and adrenal pathology. Perioperative parameters and postoperative steroidal replacement were also assessed.
RESULTS: Median follow-up was 53.9 months (IQR 31.4-103.1). Rates of clinical cure, clear improvement, and failure were 61.0%, 17.1%, and 21.9% in the MIPA group, and 70.1%, 15.3%, and 14.6% in the MITA group, respectively (all P>0.54). Postoperative steroidal replacement was more common after MITA (19.5% vs. 9.9%, P=0.80). When stratified by pathology, clinical cure was significantly more frequent in PC compared to PA (86.1% vs. 52.3%, P<0.001). Complication rates were low and comparable between groups (P=0.82).
CONCLUSIONS: In selected cases, MIPA offers long-term clinical outcomes comparable to MITA, with a lower trend in steroidal replacement. Stratification by pathology confirmed the greater clinical reversibility of PC compared to PA. The clinical cure system proved applicable across disease types and surgical strategies, supporting its broader use as a pragmatic evaluative tool in adrenal surgery.